NOVARTIS

NOVARTIS logo
๐Ÿ‡จ๐Ÿ‡ญSwitzerland
Ownership
Public, Private
Established
1996-01-01
Employees
76K
Market Cap
$242.6B
Website
https://www.novartis.com/our-science/novartis-institutes-biomedical-research

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

Phase 2
Completed
Conditions
First Posted Date
2005-07-27
Last Posted Date
2015-05-12
Lead Sponsor
Novartis
Registration Number
NCT00124241

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-07-21
Last Posted Date
2008-01-15
Lead Sponsor
Novartis
Target Recruit Count
200
Registration Number
NCT00121316
Locations
๐Ÿ‡จ๐Ÿ‡ญ

This study is not being conducted in the United States, Novartis Pharma AG, Switzerland

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

First Posted Date
2005-07-21
Last Posted Date
2008-01-15
Lead Sponsor
Novartis
Target Recruit Count
400
Registration Number
NCT00121381
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Calcagno Research and Development, Gresham, Oregon, United States

๐Ÿ‡บ๐Ÿ‡ธ

Pediatric Care Medical Group, Inc., Huntington Beach, California, United States

and more 10 locations

Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

Phase 3
Completed
Conditions
First Posted Date
2005-07-18
Last Posted Date
2017-05-18
Lead Sponsor
Novartis
Target Recruit Count
288
Registration Number
NCT00120536
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Novartis Pharmaceuticals, East Hanover, New Jersey, United States

Quality of Life Study in Adults With Facial Eczema

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-07-15
Last Posted Date
2008-01-17
Lead Sponsor
Novartis
Target Recruit Count
76
Registration Number
NCT00120302
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

This study is not being conducted in the United States, Novartis Pharmaceuticals UK, Frimley, United Kingdom

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Phase 3
Completed
Conditions
First Posted Date
2005-07-08
Last Posted Date
2007-02-21
Lead Sponsor
Novartis
Target Recruit Count
720
Registration Number
NCT00117754
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Novartis Pharmaceuticals, East Hanover, New Jersey, United States

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-07-06
Last Posted Date
2007-12-17
Lead Sponsor
Novartis
Target Recruit Count
70
Registration Number
NCT00117377
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Virginia Clinical Research, Inc, Norfolk, Virginia, United States

๐Ÿ‡บ๐Ÿ‡ธ

New York University Hospital, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai School of Medicine, New York, New York, United States

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Phase 3
Completed
Conditions
First Posted Date
2005-06-22
Last Posted Date
2015-05-12
Lead Sponsor
Novartis
Registration Number
NCT00115245

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

Phase 4
Completed
Conditions
First Posted Date
2005-03-01
Last Posted Date
2007-12-21
Lead Sponsor
Novartis
Target Recruit Count
80
Registration Number
NCT00104442
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Novartis Pharmaceuticals, East Hanover, New Jersey, United States

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Completed
Conditions
First Posted Date
2004-12-06
Last Posted Date
2006-08-31
Lead Sponsor
Novartis
Target Recruit Count
66
Registration Number
NCT00098150
ยฉ Copyright 2024. All Rights Reserved by MedPath